Gene polymorphism in toll-like receptor 4: Effect on antibody production and persistence after acellular pertussis vaccination during adolescence

Journal of Infectious Diseases

Volumn 205, Issue 8, 2012, Pages 1214-1219

  Gröndahl Yli Hannuksela, Kirsi ^a   Vuononvirta, Juho ^a   Barkoff, Alex Mikael ^a   Viander, Markku ^b   Van Der Meeren, Olivier ^d   Mertsola, Jussi ^c   He, Qiushui ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; GENOMIC DNA; HEMAGGLUTININ; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TOLL LIKE RECEPTOR 4;

ADOLESCENCE; ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE; GENOTYPE; HUMAN; MALE; PERTUSSIS; PRIORITY JOURNAL; PROTEIN FOLDING; PYROSEQUENCING; SINGLE DRUG DOSE; TLR4 GENE; VACCINATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION, SECONDARY; MALE; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

EID: 84859057512     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis182     Document Type: Article

References (32)

1. He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol 2008; 3:329-39.
2. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005; 24:761-5.
3. Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 2001; 7: 526-8.
4. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16:1901-6.
5. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16:1907-16.
6. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996; 334:341-8.
7. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349-55.
8. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63.
9. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-91.
10. Racke MK, Hu W, Lovett-Racke AE. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol 2005; 26:289-91.
11. Fransen F, Stenger RM, Poelen MC, et al. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One 2010; 5:e15692.
12. Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5:156-64.
13. Kimman TG, Banus S, Reijmerink N, et al. Association of interacting genes in the Toll-like receptor signaling pathway and the antibody response to pertussis vaccination. PLoS One 2008; 3:e3665.
14. Tran Minh NN, He Q, Ramalho A, et al. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics 1999; 104:e70.
15. Edelman K, He Q, Makinen J, et al. Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 2007; 44: 1271-7.
16. Edelman KJ, He Q, Makinen JP, et al. Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. Clin Infect Dis 2004; 39:179-85.
17. Mertsola J, Van Der Meeren O, He Q, et al. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis 2010; 51:656-62.
18. Ahmad-Nejad P. Pyrosequencing of Toll-like receptor polymorphisms of functional relevance. Methods Mol Biol 2009; 496:73-87.
19. Roos A, Dieltjes P, Vossen RH, Daha MR, de Knijff P. Detection of three single nucleotide polymorphisms in the gene encoding mannosebinding lectin in a single pyrosequencing reaction. J Immunol Methods 2006; 309:108-14.
20. Lofgren J, Marttila R, Renko M, Ramet M, Hallman M. Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics. Pediatr Pulmonol 2010; 45:687-92.
21. Vuononvirta J, Toivonen L, Grondahl-Yli-Hannuksela K, et al. Nasopharyngeal bacterial colonization and gene polymorphisms of mannose- binding lectin and Toll-like receptors 2 and 4 in infants. PLoS One 2011; 6:e26198.
22. Banus S, Bottema RW, Siezen CL, et al. Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study. Clin Vaccine Immunol 2007; 14:1377-80.
23. Banus S, Stenger RM, Gremmer ER, et al. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol 2008; 9:21.
24. Theeten H, Van Damme P, Hoppenbrouwers K, et al. Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. Vaccine 2005; 23:1515-21.
25. Buisman AM, de Rond CG, Ozturk K, Ten Hulscher HI, van Binnendijk RS. Long-term presence of memory B-cells specific for different vaccine components. Vaccine 2009; 28:179-86.
26. Hendrikx LH, Ozturk K, de Rond LG, et al. Identifying longterm memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins. Vaccine 2011; 29:1431-7.
27. Ovsyannikova IG, Dhiman N, Jacobson RM, Poland GA. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Expert Rev Vaccines 2006; 5:33-43.
28. Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011; 130:547-61.
29. Tang YW, Li H, Wu H, Shyr Y, Edwards KM. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis 2007; 196:1021-5.
30. Ovsyannikova IG, Jacobson RM, Vierkant RA, Shane Pankratz V, Jacobsen SJ, Poland GA. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine 2004; 22:1914-20.
31. Jacobson RM, Poland GA, Vierkant RA, et al. The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. Hum Immunol 2003; 64:103-9.
32. Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008; 26:6183-8.